Skip to content

XOMA Corporation XOMA Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

AbbVie logo
AbbVieABBV
$7.99B+100%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$400M
KKR & Co. logo
KKR & Co.KKR
$3.91B-16.1%
Apollo Global Management logo
Apollo Global ManagementAPO
$3.15B+970%
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Market cap$746.04M+159%
Enterprise value$785.17M+152%
P/E22.1×
P/S15.4×+8.7×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Reported directly by XOMA Corporation in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfLongTermDebt.

The official record: XOMA Corporation’s 10-K, filed March 17, 2025, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's debt issuance proceeds?
XOMA Corporation (XOMA) reported debt issuance proceeds of $32.5M in Q4 2023.
What does debt issuance proceeds mean?
Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.